3beta,25-OH-7-oxo-5-cholestenoic acid
| Catalog Number | BL-M001328 |
| CAS Number | 1036844-01-5 |
| Description | 3beta,25-OH-7-oxo-5-cholestenoic acid is utilized in therapeutic interventions targeting pathologies associated with aberrant bile acid metabolism, including bile acid synthesis deficiencies and cholestatic hepatic disorders. Serving as a pivotal intermediate during cholesterol conversion to bile acids, it exerts regulatory control over hepatic bile acid synthesis mechanisms. |
| IUPAC Name | (3S,7S,10R,13R,17R)-17-[(2R)-6,7-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol |
| Synonyms | 3beta,25-dihydroxy-7-oxo-5-cholestenoic acid |
| Molecular Weight | 434.65 |
| Molecular Formula | C27H46O4 |
| Boiling Point | 595.1±40.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.1±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Canonical SMILES | CC(CCCC(C)(CO)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C |
| InChI | InChI=1S/C27H46O4/c1-17(6-5-11-25(2,31)16-28)20-7-8-21-24-22(10-13-27(20,21)4)26(3)12-9-19(29)14-18(26)15-23(24)30/h15,17,19-24,28-31H,5-14,16H2,1-4H3/t17-,19+,20-,21?,22?,23-,24?,25?,26+,27-/m1/s1 |
| InChI Key | JGEBMCVWDISKRI-MRAVHIDRSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
